Powders, the individual particles thereof coated with from about 0.5% to 10% by weight of a material which makes the powder nydrophilic, and which are free flowing as well as amenable to tabletting by direct compression are disclosed as well as a method for making such powders and tablets.

Injectable emulsion containing a medicament, a thixotropic agent and membe-forming substance having ion-exchange properties. The membrane-forming substance being a polymerizable monomer which polymerizes by reaction with a polymerizing agent.

A pharmaceutical preparation containing a compound having anti-depressive action and a 9-(aminomethyl)-9,10-dihydro-9,10-ethano- or etheno-anthracene or a non-toxic salt thereof, together with a pharmaceutical carrier is useful for the treatment of anxiety states and nervous tension with depressive syndrome, of the psychovegetative syndrome of the so-called "masked depressions", of hypochondriac behaviour as a consequence of depressive parathymic conditions and disturbed sleep.

Disclosed herein is a disposable sealed sterile closure for use primarily in radiopharmaceutical preparations. The stopper is of the type that can be pierced by a hypodermic needle to aseptically remove sterile, pyrogen-free material from a vial or generator.

The invention relates to the manufacture of novel pharmaceutical preparations and to oral dosage unit forms comprising as sole contraceptive material a gestagenic substance of the general formula: ##SPC1## In which R.sub.1 =h or an acyl group with one to four carbon atoms or an alkyl group with One to two carbon atoms, and R.sub.2 = an alkyn group with two to four carbon atoms, which may contain halogen And in which there is one ethylenic bond starting from carbon atom five to carbon atom four o...

A filter assembly is provided for filtering pharmaceutical fluid materials without danger of contaminating downstream effluent in the event of leakage of unfiltered fluid material past a filter seal, comprising, in combination, a filter housing comprising first and second housing parts; the first housing part having a first fluid chamber open at one side, a fluid port opening into the fluid chamber, and a peripheral sealing lip; the second housing part having a second fluid chamber open at one s...

Pharmaceutical compositions containing 3,3a,6,6a-tetrahydrofuro[3,4-b]furan derivatives including canadensolide and 3-epi-dihydrocanadensolide. Novel 3,3a,6,6a-tetrahydrofuro[3,4-b]furan derivatives bearing a variety of substituents in the 3- and 6-positions selected from alkyl, phenyl, alkoxycarbonyl, methylene, benzylthiomethyl and optionally substituted phenylthiomethyl. The compositions and novel compounds show anti-ulcer activity and are useful in the treatment of gastric or duodenal ulcers...

Pharmaceutical compositions containing acetyl salicylic acid or a salt thereof and a ferrous salt having 1 to 7 equivalents of acetyl salicylic acid per equivalent of ferrous ion and characterized by reduced gastric irritation without major reduction of the usual properties of the acetyl salicylic acid. The compositions are orally administrable and may be formulated in one part or in multi-parts with the parts physically separated to prevent premature reaction particularly when the composition i...

Pharmaceutical composition which comprises an insulin sensitivity enhancer in combination with other antidiabetics differing from the enhancer in the mechanism of action, which shows a potent depressive effect on diabetic hyperglycemia and is useful for prophylaxis and treatment of diabetes.

An anti-inflammatory analgesic pharmaceutical composition comprising as active ingredient a compound of the formula I ##SPC1## wherein R is a phenyl, chlorophenyl, naphthyl, pyrole, furane, furazole, thiazole, thiadiazole or pyridine group; R.sup.1 is hydrogen or alkyl having 1 to 7 carbon atoms; R.sup.2 is hydrogen, alkyl having 1 to 7 carbon atoms, alkoxy having 1 to 7 carbon atoms or dialkylamino having 1 to 7 carbon atoms per alkyl group in admixture with a pharmaceutical carrier.